ProRx LLC: 14 recalls on record

Recalls filed with 1 agency: FDA (14).

First recall on record: September 11, 2024. Most recent: November 5, 2025.

Risk classification: Class II: 14

Most recent recalls

DateAgencyProduct
November 5, 2025FDASemaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use,…D-0116-2026
November 5, 2025FDASemaglutide Injection, 8mg/3.2mL (2.5 mg/mL), 3.2mL Multidose Vial, For Subcutaneous Use,…D-0117-2026
November 5, 2025FDASemaglutide Injection, 10 mg/4 mL (2.5 mg/mL), 4mL Multidose Vial, For Subcutaneous Use, …D-0115-2026
November 5, 2025FDASemaglutide Injection, 12.5/5mL (2.5 mg/mL), 5mL Multidose Vial, For Subcutaneous Use, Rx…D-0114-2026
November 5, 2025FDASemaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneous Use, R…D-0119-2026
November 5, 2025FDATirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx…D-0120-2026
November 5, 2025FDASemaglutide Injection, 2.5mg/1mL (2.5 mg/mL), 1mL Multidose Vial, For Subcutaneous Use, R…D-0118-2026
September 11, 2024FDATIRZEPATIDE 20 mg/2mL (10/mg/mL), Rx Only, 2mL Multiple Dose Vial, Mfd by: ProRx Exton, …D-0655-2024
September 11, 2024FDASemaglutide, 2 mL (2.5mg/mL), Compounded RX Product, Multidose SC inj, glass vial, ProRx…D-0650-2024
September 11, 2024FDASEMAGLUTIDE 10mg/4mL (2.5mg/mL), 4 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd b…D-0653-2024
September 11, 2024FDATirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx…D-0651-2024
September 11, 2024FDASEMAGLUTIDE 5mg/2mL (2.5mg/mL), Rx Only 2 mL Multiple Dose Vial, Rx Only, Compounded Drug…D-0652-2024
September 11, 2024FDATIRZEPATIDE 60 mg/3mL (20/mg/mL), Rx Only, 3mL Multiple Dose Vial, Mfd by: ProRx Exton, …D-0656-2024
September 11, 2024FDASemaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mL, 2 mL Multiple Dose Vial, Compound…D-0654-2024

Questions about this company

How many recalls does ProRx LLC have?
Recalert has 14 U.S. recalls on record for ProRx LLC, published between September 11, 2024 and November 5, 2025.
What was the most recent ProRx LLC recall?
FDA recall D-0116-2026, published November 5, 2025: Semaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-08
Which agencies have handled ProRx LLC recalls?
ProRx LLC appears as the recalling firm in recalls from: FDA (14).

Do you carry products from ProRx LLC? Check your whole catalog free against 80,000+ recalls.

Paste up to 100 UPCs or SKUs and see which ones match a CPSC, FDA, NHTSA or FSIS recall. No account needed.

Check my catalog free

Want it checked every night instead? Starter watches 500 SKUs for $29/month. See plans

Related companies